Overview

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Status:
Completed

Trial end date:
2010-11-01

Target enrollment:

Participant gender:

Summary

The primary objective of this trial is to evaluate the clinical efficacy and safety of aripiprazole in comparison to placebo in patients with Bipolar I Disorder experiencing a manic or mixed episode.

Phase:

Phase 3

Details

Lead Sponsor:

Otsuka Pharmaceutical Co., Ltd.

Treatments:

Aripiprazole